Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by Jaro1977on May 31, 2024 12:24am

255 Views

Post# 36065726

List of Questions to Ask at AGM

email: mperraton@theralase.com

1.) Will Theralase have to treat, in total, 100 patients in order to re-submitt/submitt the pre-BTD/BTD?
2.) Have all treated patients given consent for their 450 days data to be submitted for review?
3.) How much capital does Theralse project to be able to raise via debt issuance and by what date?
4.) Why is the Leadership Team at Theralase (CEO, CFO, CSS), not foregoing compensation, (et al. Ryan Cohen, Gamestop) in favor of stock/options, in order to further the company development, share holder value, lower overhead, increased spending for sudy sites, etc.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland